CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 5 enrolled
Drug / intervention
Platelet-Rich Plasmacombination
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03667638
NCT03667638N/ACompleted
CompareCT.gov

The Influence of Autologous Platelet Concentrates on Human Keratinocyte Proliferation in Vitro and Wound Healing in Vivo

Hannover Medical School·interventional·Posted Sep 12, 2018·Updated Sep 12, 2018

In Brief

A clinical study evaluating Platelet-Rich Plasma for Platelet-Rich Plasma and Wound Healing Delayed. Completed, enrolled 5 participants across 1 site.

Detailed Summary

Chronic soft tissues defects can extend into the fat layer or even deeper and can cause functional disadvantages. Split-thickness skin grafts (STSGs) used to cover these wounds have varying success rates. To improve wound healing in chronic wounds the authors have studied the application of autologous platelet concentrates in a human keratinocyte culture model in vitro and in a combination with surgical procedures in vivo as second line therapy in patients with initially failed wound closure.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPlatelet-Rich Plasma, Wound Healing Delayed
CountriesGermany
Collaborators--

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedSep 12, 2018
Enrollment StartNov 1, 2016
Primary CompletionNov 1, 2017
Study CompletionDec 1, 2017
TodayJul 2, 2026
Enrollment to primary: 1 yearPosted 7.8 years ago

Interventions

Platelet-Rich Plasmacombination

Adding PRP to wound bed during surgical debridement